Pezzella, Michele
Quintarelli, Concetta
Quadraccia, Maria C.
Sarcinelli, Andrea
Manni, Simona
Iaffaldano, Laura
Ottaviani, Alessio
Ciccone, Roselia
Camera, Antonio
D’Amore, Maria L.
Di Cecca, Stefano
Sinibaldi, Matilde
Guercio, Marika
Aurigemma, Mariasole
De Falco, Pamela
Fustaino, Valentina
Rota, Rossella
Pomella, Silvia
Cassandri, Matteo
Di Giannatale, Angela
Agrati, Chiara
Bordoni, Veronica
Guarracino, Federica
Massa, Michele
Del Baldo, Giada
Becilli, Marco
Milano, Giuseppe M.
Del Bufalo, Francesca
Locatelli, Franco
De Angelis, Biagio
Funding for this research was provided by:
Ministero della Salute (Ricerca Finalizzata GR-2013-02359212 (CQ), Progetto Ministeriale CAR-T (FL), Ricerca Corrente 5X1000 (BDA))
Ministry of Health and Alleanza Contro il Cancro-Working Group Sarcoma (ACC-WG Sarcoma (FL))
Associazione Italiana Ricerca per la Ricerca sul Cancro (AIRC-Special Project 5×1000 no. 9962 (FL))
Associazione Italiana Ricerca per la Ricerca sul Cancro Investigator Grant (AIRC IG 2018 id. 21724 (FL), AIRC-IG ID. 29057 (BDA))
IMI JU/T2EVOLVE (grant number 945393 (FL))
PNRR CN3 “National Center for Gene Therapy and Drugs based on RNA Technology” (European Union - Next Generation EU, Mission 4, Component 2, CUP B93D21010860004)
Alleanza Contro il Cancro (Grant Rete ACC RCR-2022-23682287 Preclinical Models (BDA))
Article History
Received: 11 July 2024
Accepted: 19 November 2024
First Online: 18 December 2024
Declarations
:
: Not applicable.
: The authors declare no competing interests.